Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC51 Batch Consistency Study
NCT00594958Phase 3Completed
- Sponsor
- Valneva
- Start
- Sep 2006
- Primary completion
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE) (3 arms), sponsored by Valneva. Primary endpoint: Geometric Mean Titers for Anti-JEV Neutralizing Antibody at Day 56. Started Sep 2006; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00594958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594958.